Inventor

SPERGEL STEVEN H

US40 patents

⚠️ This page may combine multiple inventors who share the name “SPERGEL STEVEN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SPERGEL STEVEN H

BRISTOL MYERS SQUIBB CO

Thiazolyl inhibitors of Tec family tyrosine kinases

Substituted biphenyl isoxazole sulfonamides

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Imidazoquinoxaline protein tyrosine kinase inhibitors

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Thiazolyl inhibitors of Tec family tyrosine kinases

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Process for preparing N-protected amino acid α-halomethyl ketones and alcohols from N-protected amino acid esters

Substituted isoxazole compounds

Substituted heterocyclic compounds

Aminotriazolopyridines as kinase inhibitors

Imidazoquinoxaline protein tyrosine kinase inhibitors

Retrocarbamate protease inhibitors

Triazolopyridinyl compounds as kinase inhibitors

Thiazolyl inhibitors of Tec family tyrosine kinases

Thiazolyl inhibitors of Tec family tyrosine kinases

Thiazolyl inhibitors of Tec family tyrosine kinases

Thiazolyl inhibitors of Tec family tyrosine kinases

Aminotriazolopyridines as kinase inhibitors

Aminoimidazopyridazines as kinase inhibitors

1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same

8H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Triazolopyridinyl compounds as kinase inhibitors

Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same

Substituted heterocyclic compounds

Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators

Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses

WROBLESKI STEPHEN T

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

SQUIBB & SONS INC

Tetrahydroethanonaphthaleneamine derivatives

Tetrahydroethanonaphthaleneamine derivatives

PITTS WILLIAM J

Substituted heterocyclic compounds

1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same